RYOIX Rating, Research - Rydex Biotechnology Inv

Rydex Biotechnology Inv (ryoix)

Last Updated by Anonymous | Update This Page Now

►Summary | Add New Mutual Fund | Feedback

Short Term Rating Stock Ratings Help

Asset Allocation (% of Port)

US Stocks
Non-US Stocks

Geographic Allocation (% of Port)

North America
South America
Australia + Pacific Islands
Long Term Rating Stock Ratings Help


SWOT Statistics

Strengths + Opportunities = 39

Threats + Weaknesses = 31

When strengths & opportunities substantially exceed threats & weaknesses an investment in the ryoix mutual fund has great long term potential.

Fund Management Team

Fund Description Update

Rydex Biotechnology Inv (RYOIX) Description: RYOIX is a mutual fund, which is an investment that owns a basket of assets. The RYOIX mutual fund was provided by Rydex and this investment vehicle derives the majority of its value from equity holdings (stocks). Rydexs mutual fund has a long management tenure and is in the small fund size classification. RYOIXs minimum initial investment amount is $2500 while the IRA minimum is $1000. RYOIXs expense ratio is roughly 1%. The latest RYOIXs front end load was 0% and the back end load was 0%. The Rydex Biotechnology Inv (RYOIX) mutual fund falls under the health category. RYOIX focuses its investments in USA and RYOIX is focused on the health industry or fund sector. The Rydex Biotechnology Inv (RYOIX) mutual fund is not a leveraged fund and it does not have inverse fund properties. An investor can find RYOIXs top holdings, fundamental analysis, ratings, and fund risk (volatility) on the left side of the screen. The right side of RYOIXs research report features technical analysis and long term investment potential.

Portfolio Strategy Update

This investment vehicle seeks capital appreciation. The fund invests substantially at least 80% of its net assets in equity securities (see equity research) of Biotechnology Companies that are traded in the United States and derivatives. Biotechnology Companies are engaged in the research, development, and manufacture of various biotechnology-cal products, services, and processes; manufacture and/or distribute biotechnological and biomedical products. It invests to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The funds non-diversified.

Management Analysis Update

Rydex Biotechnology Inv's executives / managers make better investing decisions, because their assets are invested along side their client's. The ryoix fund does not have a history of big fund withdrawals. This helps reduce large tax payments to current investors.

Performance Analysis Update